Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr-cas9
2
×
editas medicine
gene editing
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
advaxis
agios therapeutics
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
base editing
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakup
bridge bio pharma
broad institute
cas13
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr
crispr therapeutics
david liu
delisting
democrats
departure
detroit blog main
What
cas
crispr
editas
2
×
medicine
2
×
beam
big
bio
bosley's
bosley’s
bridge
bucks
ceo
crime
departure
editing
editor
exit
founders
gene
gotten
guiding
harvard
jump
katrine
mass
moves
personnel
precise
roundup
scientists
spotlights
startup
surprising
therapeutics
university
version
week
Language
Current search:
editas
×
crispr-cas9
×
medicine
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M